
Hitesh Chandrakant Bari
About Hitesh Chandrakant Bari
Data last updated:
Hitesh Chandrakant Bari is a Director at Unigrace Pharmaceuticals Private Limited (since 2016) and Designated Partner at Metrocare Pharma Llp (since 2026). The companies operate in Chemicals. The largest current company by reported revenue is Unigrace Pharmaceuticals Private Limited at ₹39,966 (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 13 Apr 2016 | 2016 | ₹39,966 (FY 2023) | Active | |
| Designated Partner | 12 Jan 2026 | 2026 | Active |
Board colleagues of Hitesh Chandrakant Bari
| Name | DIN | Company | Designation |
|---|---|---|---|
| Shyamal Hitesh Bari | 07425657 | Unigrace Pharmaceuticals Private Limited | Director |
| Mahendra Purushottam Chaudhary | 11479650 | Metrocare Pharma Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hitesh Chandrakant Bari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hitesh Chandrakant Bari
Hitesh Chandrakant Bari currently holds 2 directorships: Unigrace Pharmaceuticals Private Limited (Director, since 13 Apr 2016, revenue ₹39,966 (FY 2023)); Metrocare Pharma Llp (Designated Partner, since 12 Jan 2026).
Hitesh Chandrakant Bari was first appointed on 13 Apr 2016 as Director at Unigrace Pharmaceuticals Private Limited. The most recent appointment on record is 12 Jan 2026 at Metrocare Pharma Llp.
The current boards of Hitesh Chandrakant Bari's companies include Shyamal Hitesh Bari (Unigrace Pharmaceuticals Private Limited), Mahendra Purushottam Chaudhary (Metrocare Pharma Llp).